Home Pingan Tsumura Acquires China Medico to Become the Controlling Shareholder

Pingan Tsumura Acquires China Medico to Become the Controlling Shareholder

CST Updated Apr 02, 2020 09:12

According to prnasia.com, Pingan Tsumura has announced the acquisition of Tianjin China Medico Technology Co., Ltd. ("China Medico") in a transaction of 1.2 billion yuan, with the assistance of China Ping An Insurance Overseas (Holdings) Ltd. ("PAOH") and TSUMURA & CO. ("Tsumura"). After completion of the deal, Pingan Tsumura will become the controlling shareholder of China Medico with an 80 percent stake. 


The acquisition will further improve the crude drug platform of Pingan Tsumura, guarantee the supply of traditional Chinese medicine raw materials, promote the quality management and production of crude drugs. In addition, the experienced talents and teams of China Medico in the Chinese medicine industry will help Pingan Tsumura further expand its business in China.


China Medico is a leading enterprise in the Chinese herbal medicine industry, focusing on the standardized planting of high-quality Chinese herbal medicines, as well as the production and operation of herbal decoction pieces. 


China Medico deals in over 100 types of Chinese herbal medicines bulk products, including ginseng, licorice, pinellia, asarum, ephedra, etc., and more than 300 kinds of herbal decoction pieces products. The company ranks No. 1 among all Chinese herbal decoction pieces export enterprises in 2017 and No.3 among the traditional Chinese herbal medicine export enterprises, among which, ginseng exports have ranked No. 1 for several years since 2012.


China Medico, relying on its international business resources, has conducted layout of the whole industry chain resources in the field of Chinese herbal medicines and herbal decoction pieces.


Pingan Tsumura is a joint venture established by Ping An Insurance (Group) Company of China, Ltd. ("Ping An") and Tsumura in China to jointly enhance traditional Chinese medicine research, development and production technology and to build and perfect the whole industry chain quality management standard system of traditional Chinese medicine from herbs cultivation to the final product.